MontiFast 4 mg (Chewable Tablet)
Unit Price: ৳ 7.00 (2 x 10: ৳ 140.00)
Strip Price: ৳ 70.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Montelukast sodium |
| Company | Globe pharmaceuticals ltd |
| Also available as |
Product Title
- MontiFast 4 mg Chewable Tablet
Product Categories
- Medicine
- Health & Wellness
- Respiratory Care
Indications
- Prophylaxis and chronic treatment of asthma
- Acute prevention of Exercise-Induced Bronchoconstriction (EIB)
- Relief of symptoms of Allergic Rhinitis: Seasonal & Perennial Allergic Rhinitis
Pharmacology
- Selective and orally active leukotriene receptor antagonist
- Inhibits the cysteinyl leukotriene receptor (CysLT1)
- Correlated with the pathophysiology of asthma & allergic rhinitis
Dosage & Administration
- Dosage for adults and adolescents 15 years of age and older: Montelukast 10 mg tablet once daily
- Dosage for pediatric patients 6 to 14 years of age: Montelukast 5 mg tablet once daily
- Dosage for pediatric patients 2 years to 5 years of age: Montelukast 4 mg tablet once daily
- Dosage for pediatric patients 6 months to 5 years of age: Montelukast 4 mg oral granules once daily
Interaction
- No clinically important effects on the pharmacokinetics of certain drugs
- Used concomitantly with a wide range of commonly prescribed drugs without evidence of clinical adverse interactions
Contraindications
- Hypersensitivity to any component of the product
Side Effects
- Common: Diarrhoea, fever, headache, skin reactions
- Uncommon: Anxiety, depression, dizziness, dry mouth
- Rare: Angioedema, memory loss, palpitations, suicidal tendencies
Pregnancy & Lactation
- Crosses the placenta following oral dosing in rats and rabbits
- Use during pregnancy only if clearly needed
- Caution should be exercised when given to a nursing mother
Precautions & Warnings
- Not indicated for use in the reversal of bronchospasm in acute asthma attacks
- Patients should have appropriate rescue medication available
- Should not be used as monotherapy for the treatment of exercise induced bronchospasm
Overdose Effects
- Supportive measures may be employed in the event of overdose
- Most frequently occurring adverse experiences include abdominal pain, somnolence, headache
Therapeutic Class
- Leukotriene receptor antagonists
Storage Conditions
- Store in cool & dry place below 30°C, protect from light & moisture
Chemical Structure
- Molecular Formula: C35H36ClNO3S (Montelukast Sodium)
Common Questions
- Effect of MontiFast 4 mg Chewable Tablet can be observed after 1-3 hours of administration
- Effect lasts for an average duration of 24 hours
- May be taken with or without food as prescribed by a doctor
- Use in pregnant women should be avoided unless clearly needed